Cite
HARVARD Citation
Panés, J. et al. (n.d.). P516 Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trials. Journal of Crohn's and colitis. pp. S366-S367. [Online].